A new dataset for predicting antigen-antibody interactions, published in the prestigious machine learning conference NeurIPS 2023, will help accelerate AI drug discovery KYOTO, Japan--(BUSINESS WIRE)- ...

In a recent study published in Nature Machine Intelligence, a team of researchers used a deep antibody-antigen interaction (DeepAAI) algorithm to understand the antibody representations of unseen ...

KYOTO, Japan--(BUSINESS WIRE)--A joint research paper on artificial intelligence (AI)-driven drug discovery by “SAKURA internet Research Center,” an in-house research institute of SAKURA internet Inc.

SEATTLE, May 16, 2023 — A-Alpha Bio, a synthetic biology and machine learning company that measures and engineers protein-protein interactions, and Lawrence Livermore National Laboratory (LLNL) today ...

Osaka, Japan – Protein detection based on antigen–antibody reaction is vital in early diagnosis of a wide range of diseases. How to effectively detect proteins, however, has frequently bedeviled ...

Antibodies represent the fastest growing class of drugs in the market today, with over 60 antibody drugs currently approved for use and more than 550 in clinical development 1. They are highly ...

As a basic description, an antibody can be described as any molecule that has epitopes (antigenic sites) that fit with corresponding antibodies, initiating an immune response. Antigens come in many ...

Among the most promising tools of cancer therapy, engineered immune cells known as chimeric antigen-receptor (CAR) T cells have already transformed the treatment of blood cancers. Yet, despite their ...

Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer Following investigational new ...

Immunoassays are measurement procedures that use immune-based reagents to generate a detectable signal, allowing scientists to quantify biological processes. Scientists perform immunoassays to measure ...